| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
20,181 |
18,980 |
$4.64M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
26,200 |
24,841 |
$4.31M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
12,035 |
11,198 |
$3.15M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
3,881 |
3,687 |
$2.44M |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,488 |
1,410 |
$649K |
| 70450 |
Computed tomography, head or brain; without contrast material |
2,308 |
2,225 |
$560K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
6,008 |
5,748 |
$413K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
349 |
339 |
$177K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
546 |
524 |
$167K |
| 93975 |
|
261 |
251 |
$35K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
633 |
596 |
$31K |
| 12001 |
|
341 |
336 |
$30K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,233 |
1,133 |
$30K |
| 73562 |
|
292 |
280 |
$28K |
| 93971 |
|
175 |
168 |
$23K |
| 72131 |
|
31 |
29 |
$12K |
| 73630 |
|
1,019 |
992 |
$5K |
| 73130 |
|
773 |
739 |
$4K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
106 |
102 |
$3K |
| 73110 |
|
410 |
399 |
$3K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
9,419 |
8,573 |
$2K |
| 93976 |
|
507 |
480 |
$2K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
10,443 |
9,555 |
$2K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
7,861 |
7,245 |
$848.14 |
| 73030 |
|
525 |
500 |
$723.78 |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
3,516 |
3,429 |
$699.18 |
| 12011 |
|
12 |
12 |
$638.89 |
| 10060 |
|
53 |
50 |
$627.33 |
| 76801 |
|
638 |
578 |
$595.10 |
| 73564 |
|
155 |
148 |
$584.73 |
| 71046 |
Radiologic examination, chest; 2 views |
8,766 |
8,378 |
$556.15 |
| 73080 |
|
91 |
88 |
$476.32 |
| 87400 |
|
6,691 |
5,302 |
$414.57 |
| 73610 |
|
1,003 |
970 |
$411.89 |
| 73140 |
|
69 |
68 |
$297.95 |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
1,262 |
1,195 |
$279.60 |
| 80053 |
Comprehensive metabolic panel |
17,504 |
16,126 |
$274.26 |
| 87631 |
|
701 |
691 |
$267.62 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
3,044 |
2,918 |
$233.57 |
| 72100 |
|
45 |
44 |
$218.13 |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,455 |
1,396 |
$121.08 |
| 29515 |
|
87 |
84 |
$102.36 |
| 87081 |
|
3,437 |
3,365 |
$60.02 |
| 87186 |
|
1,349 |
1,282 |
$59.87 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
4,626 |
4,474 |
$55.30 |
| 74018 |
|
496 |
479 |
$49.62 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
515 |
462 |
$37.60 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
591 |
567 |
$32.39 |
| 81001 |
|
9,955 |
9,378 |
$25.66 |
| 81025 |
|
4,445 |
4,250 |
$17.56 |
| 87430 |
|
3,735 |
3,656 |
$16.54 |
| 82962 |
|
744 |
680 |
$6.50 |
| 81003 |
|
4,919 |
4,668 |
$4.85 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
8,096 |
7,508 |
$3.15 |
| 84702 |
|
1,016 |
917 |
$0.00 |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
2,477 |
2,386 |
$0.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
2,696 |
2,505 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
5,171 |
4,910 |
$0.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
60 |
53 |
$0.00 |
| 85610 |
|
1,235 |
1,168 |
$0.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
3,228 |
2,938 |
$0.00 |
| 90715 |
|
574 |
557 |
$0.00 |
| 87420 |
|
1,609 |
1,569 |
$0.00 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
462 |
427 |
$0.00 |
| 87210 |
|
65 |
61 |
$0.00 |
| 86900 |
|
348 |
337 |
$0.00 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
347 |
306 |
$0.00 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
127 |
125 |
$0.00 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
458 |
444 |
$0.00 |
| 29125 |
|
234 |
229 |
$0.00 |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
3,132 |
2,859 |
$0.00 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
93 |
90 |
$0.00 |
| 82009 |
|
36 |
36 |
$0.00 |
| 73590 |
|
12 |
12 |
$0.00 |
| 80076 |
|
12 |
12 |
$0.00 |
| 82550 |
|
408 |
392 |
$0.00 |
| 83690 |
|
8,167 |
7,568 |
$0.00 |
| 83735 |
|
6,123 |
5,763 |
$0.00 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,846 |
2,723 |
$0.00 |
| 85379 |
|
1,296 |
1,236 |
$0.00 |
| 84443 |
Thyroid stimulating hormone (TSH) |
848 |
822 |
$0.00 |
| 84703 |
|
5,446 |
5,133 |
$0.00 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,193 |
1,927 |
$0.00 |
| 86901 |
|
348 |
337 |
$0.00 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
19,791 |
18,145 |
$0.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
8,431 |
7,878 |
$0.00 |
| 87088 |
|
3,362 |
3,177 |
$0.00 |
| 83880 |
|
610 |
578 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,688 |
1,599 |
$0.00 |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
13,106 |
12,091 |
$0.00 |
| 71045 |
Radiologic examination, chest; single view |
4,052 |
3,865 |
$0.00 |
| J1790 |
Injection, droperidol, up to 5 mg |
554 |
507 |
$0.00 |
| J2060 |
Injection, lorazepam, 2 mg |
445 |
412 |
$0.00 |
| J3490 |
Unclassified drugs |
993 |
888 |
$0.00 |
| 85730 |
|
582 |
546 |
$0.00 |
| A9270 |
Non-covered item or service |
69 |
64 |
$0.00 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
1,207 |
1,144 |
$0.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,784 |
4,535 |
$0.00 |
| 83605 |
|
1,262 |
1,179 |
$0.00 |
| 76830 |
Ultrasound, transvaginal |
306 |
288 |
$0.00 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
143 |
131 |
$0.00 |
| 84484 |
|
5,302 |
4,690 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
3,898 |
3,749 |
$0.00 |
| 87040 |
|
101 |
91 |
$0.00 |
| 87077 |
|
616 |
573 |
$0.00 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
153 |
151 |
$0.00 |
| 96376 |
|
654 |
609 |
$0.00 |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
139 |
128 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
528 |
501 |
$0.00 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
380 |
366 |
$0.00 |
| A9150 |
Non-prescription drugs |
141 |
137 |
$0.00 |
| J7999 |
Compounded drug, not otherwise classified |
14 |
14 |
$0.00 |
| 74021 |
|
14 |
14 |
$0.00 |
| 87147 |
|
60 |
59 |
$0.00 |
| 85027 |
|
106 |
100 |
$0.00 |
| J3360 |
Injection, diazepam, up to 5 mg |
27 |
26 |
$0.00 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
30 |
27 |
$0.00 |
| J3590 |
Unclassified biologics |
27 |
27 |
$0.00 |
| J1630 |
Injection, haloperidol, up to 5 mg |
93 |
86 |
$0.00 |
| J7050 |
Infusion, normal saline solution, 250 cc |
15 |
13 |
$0.00 |
| 73090 |
|
29 |
28 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
24 |
21 |
$0.00 |